RNA methylation is a novel epigenetic modification that can be used to evaluate tumor prognosis. However. the underlying mechanisms are unclear. This study aimed to investigate the genetic characteristics of 5-methylcytosine (m5C) and N1-methyladenosine (m1A) regulators in lung squamous cell carcinoma (LUSC) and the prognostic value and immune-related effects of m5C regulators. https://www.foldlyers.shop/product-category/2-way-5-25/